Global Pharyngitis Market Trend Evaluation and Future Forecast during the Period 2017-2026

Posted on 2018-06-29 by Mark Hub in Healthcare // 0 Comments

Fact MR

Rockville, US, 2018-Jun-29 — /EPR Network/ — A fresh report has been added to the wide database of FactMR titled “Pharyngitis Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” gives an outlook of mannequin market value in 2017 and the expected scenario of Rate on Investment (ROI) with growing CAGR by the end of 2026. The report also studies the market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions during same stated forecast to 2026.

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=361

As per the report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register 3.4% CAGR during the forecast period 2017-2026. The global pharyngitis market is also estimated to reach US$ 1,679.0 million revenue by the end of 2026. Pharyngitis is the most common problem among people. It is mostly caused due to other illness such as flu, cold, or mononucleosis it results in sore throat. Most of the health providers diagnose pharyngitis with the help of rapid strep test. Medicines are given by doctor only after determining whether the infection is viral or bacterial. Hence, manufacturers of drugs are conducting research to develop more effective drugs to treat pharyngitis. Below are few insights on how the global pharyngitis market will perform in the coming years.

5 Forecast Highlights on Global Pharyngitis Market

1- Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.

2- North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.

3- Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.

View Full Report with TOC@ https://www.factmr.com/report/361/pharyngitis-market

4- Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.

5- Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.

Buy this Report@ https://www.factmr.com/checkout/361/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick